281 related articles for article (PubMed ID: 29893703)
21. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
[TBL] [Abstract][Full Text] [Related]
22. Urine neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury and prognosis in decompensated chronic liver disease: A prospective study.
Yewale RV; Ramakrishna BS; Venugopal G; Doraiswami BV; Rajini K
Indian J Gastroenterol; 2023 Feb; 42(1):106-117. PubMed ID: 36763249
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.
Gomaa SH; Shamseya MM; Madkour MA
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):692-702. PubMed ID: 30601335
[TBL] [Abstract][Full Text] [Related]
24. Urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C measurements for early diagnosis of acute kidney injury in children admitted to PICU.
Kari JA; Shalaby MA; Sofyani K; Sanad AS; Ossra AF; Halabi RS; Aljuhani MH; Toffaha WM; Moria FA; Sabry S; Ahmed HA; Alhasan KA; Sharief S; Safdar O
World J Pediatr; 2018 Apr; 14(2):134-142. PubMed ID: 29464581
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.
Kafkas N; Liakos C; Zoubouloglou F; Dagadaki O; Dragasis S; Makris K
Clin Cardiol; 2016 Aug; 39(8):464-70. PubMed ID: 27175937
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Urinary Neutrophil Gelatinase-Associated Lipocalin on the First Day of Admission for Adverse Events in Patients With Acute Decompensated Heart Failure.
Nakada Y; Kawakami R; Matsui M; Ueda T; Nakano T; Takitsume A; Nakagawa H; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Kawata H; Okura H; Saito Y
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522674
[TBL] [Abstract][Full Text] [Related]
27. Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients.
Taghizadeh-Ghehi M; Sarayani A; Ashouri A; Ataei S; Moslehi A; Hadjibabaie M
Ren Fail; 2015 Jul; 37(6):994-8. PubMed ID: 25945602
[TBL] [Abstract][Full Text] [Related]
28. Early Diagnosis Of Acute Kidney Injury By Urinary Neutrophil Gelatinase Associated Lipocalin In Adult Critically Ill Patients.
Shoaib M; Mahmud SN; Safdar M
J Ayub Med Coll Abbottabad; 2019; 31(1):12-15. PubMed ID: 30868775
[TBL] [Abstract][Full Text] [Related]
29. Acute Kidney Injury in Liver Disease: Role of Biomarkers.
Belcher JM
Adv Chronic Kidney Dis; 2015 Sep; 22(5):368-75. PubMed ID: 26311598
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study.
Gungor G; Ataseven H; Demir A; Solak Y; Gaipov A; Biyik M; Ozturk B; Polat I; Kiyici A; Cakir OO; Polat H
Liver Int; 2014 Jan; 34(1):49-57. PubMed ID: 23799980
[TBL] [Abstract][Full Text] [Related]
31. Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis.
Vanmassenhove J; Glorieux G; Lameire N; Hoste E; Dhondt A; Vanholder R; Van Biesen W
BMC Nephrol; 2015 Feb; 16():18. PubMed ID: 25868473
[TBL] [Abstract][Full Text] [Related]
32. The Update of NGAL in Acute Kidney Injury.
Shang W; Wang Z
Curr Protein Pept Sci; 2017; 18(12):1211-1217. PubMed ID: 27634444
[TBL] [Abstract][Full Text] [Related]
33. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study.
Zappitelli M; Washburn KK; Arikan AA; Loftis L; Ma Q; Devarajan P; Parikh CR; Goldstein SL
Crit Care; 2007; 11(4):R84. PubMed ID: 17678545
[TBL] [Abstract][Full Text] [Related]
34. Clinical Application of Kidney Biomarkers in Cirrhosis.
Allegretti AS; Solà E; Ginès P
Am J Kidney Dis; 2020 Nov; 76(5):710-719. PubMed ID: 32622560
[TBL] [Abstract][Full Text] [Related]
35. Urinary exosomal activating transcriptional factor 3 as the early diagnostic biomarker for sepsis-induced acute kidney injury.
Panich T; Chancharoenthana W; Somparn P; Issara-Amphorn J; Hirankarn N; Leelahavanichkul A
BMC Nephrol; 2017 Jan; 18(1):10. PubMed ID: 28061889
[TBL] [Abstract][Full Text] [Related]
36. Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study.
Zwiers AJ; de Wildt SN; van Rosmalen J; de Rijke YB; Buijs EA; Tibboel D; Cransberg K
Crit Care; 2015 Apr; 19(1):181. PubMed ID: 25895828
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil Gelatinase-associated Lipocalin as a Marker of Postoperative Acute Kidney Injury Following Cardiac Surgery in Patients with Preoperative Kidney Impairment.
Tidbury N; Browning N; Shaw M; Morgan M; Kemp I; Matata B
Cardiovasc Hematol Disord Drug Targets; 2019; 19(3):239-248. PubMed ID: 30987577
[TBL] [Abstract][Full Text] [Related]
38. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients.
Makris K; Markou N; Evodia E; Dimopoulou E; Drakopoulos I; Ntetsika K; Rizos D; Baltopoulos G; Haliassos A
Clin Chem Lab Med; 2009; 47(1):79-82. PubMed ID: 19055468
[TBL] [Abstract][Full Text] [Related]
39. Combination of Urinary Neutrophil Gelatinase-associated Lipocalin, Kidney Injury Molecular-1, and Angiotensinogen for the Early Diagnosis and Mortality Prediction of Septic Acute Kidney Injury.
Li N; Zhang X; Wan P; Yu M; Min J
Comb Chem High Throughput Screen; 2024; 27(7):1033-1045. PubMed ID: 37855356
[TBL] [Abstract][Full Text] [Related]
40. Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study.
Kim TH; Seo YS; Kang SH; Kim MY; Kim SG; Lee HY; Lee JH; Lee YS; Kim JH; Jeong SW; Jang JY; Suk KT; Jung YK; An H; Yim HJ; Kim YS; Um SH;
Liver Int; 2020 Dec; 40(12):3083-3092. PubMed ID: 32750739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
